New Haven bioscience startup Rallybio Corp. announced that Dr. Stephen Uden will be elevated to the CEO position as of Aug. 1.
A company co-founder, Uden is currently president and chief operating officer.
He will succeed Martin Mackay, who will assume the role of executive chairman, a full-time position through which he will focus on company strategy, investor relations and related activities.
Uden was previously head of research at Alexion Pharmaceuticals Inc.
